S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
CVE:WMD

WeedMD (WMD) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free WMD Stock Alerts
C$0.28
-0.01 (-1.79%)
(As of 07/15/2021)
Compare
Today's Range
C$0.28
▼
C$0.29
50-Day Range
C$0.28
▼
C$0.28
52-Week Range
C$0.23
▼
C$0.99
Volume
271,436 shs
Average Volume
766,591 shs
Market Capitalization
C$67.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
WMD stock logo

About WeedMD Stock (CVE:WMD)

WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.

WMD Stock Price History

WMD Stock News Headlines

March 4, 2024 | dailymail.co.uk
'Truth about WMD will finally emerge'
October 5, 2023 | dailymail.co.uk
Blair: 'Saddam still has weapons of mass destruction'
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
May 20, 2023 | dailymail.co.uk
'Weapons of mass destruction found'
May 14, 2023 | thestreet.com
The Next Financial WMD?
March 22, 2023 | reuters.com
Column: The road to war: An ex-Reuters journalist recalls the chase for WMD in Iraq
September 16, 2022 | financialpost.com
Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer - Financial Post
September 7, 2022 | finance.yahoo.com
CORRECTING and REPLACING BevCanna Provides Corporate and Operational Update - Yahoo Finance
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
September 7, 2022 | businesswire.com
BevCanna Provides Corporate and Operational Update - Business Wire
August 30, 2022 | streetinsider.com
Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program - StreetInsider.com
August 29, 2022 | globenewswire.com
Entourage Health Reports Second Quarter 2022 Financial Results - GlobeNewswire
August 4, 2022 | streetinsider.com
Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada - StreetInsider.com
July 29, 2022 | finance.yahoo.com
Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures - Yahoo Finance
July 28, 2022 | globenewswire.com
Entourage Expands Medical Offerings with Launch of New Services and Products - GlobeNewswire
July 26, 2022 | streetinsider.com
Entourage Expands Medical Offerings with Launch of New Services and Products - StreetInsider.com
June 21, 2022 | finance.yahoo.com
Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures - Yahoo Finance
June 20, 2022 | finance.yahoo.com
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures - Yahoo Finance
June 15, 2022 | financialpost.com
Entourage Announces Results of 2022 Annual General Meeting of Shareholders - Financial Post
June 15, 2022 | finance.yahoo.com
Entourage Announces Results of 2022 Annual General Meeting of Shareholders - Yahoo Finance
June 15, 2022 | streetinsider.com
Entourage Announces Results of 2022 Annual General Meeting of Shareholders - StreetInsider.com
May 30, 2022 | financialpost.com
Entourage Health Reports Record First Quarter 2022 Financial Results - Financial Post
May 20, 2022 | finance.yahoo.com
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022 - Yahoo Finance
May 13, 2022 | finance.yahoo.com
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures - Yahoo Finance
May 10, 2022 | stockhouse.com
2022-05-10 | TSXV:ENTG | Press Release | Entourage Health - Stockhouse
May 4, 2022 | finance.yahoo.com
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients - Yahoo Finance
April 29, 2022 | globenewswire.com
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability - GlobeNewswire
See More Headlines
Receive WMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WeedMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:WMD
CUSIP
N/A
CIK
N/A
Web
www.weedmd.com
Phone
+1-416-5153923
Fax
N/A
Employees
212
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
95.63
Current Ratio
3.46
Quick Ratio
1.46

Sales & Book Value

Annual Sales
C$27.53 million
Price / Sales
2.46
Cash Flow
C$0.08 per share
Price / Cash Flow
3.27
Book Value
C$0.34 per share
Price / Book
0.81

Miscellaneous

Outstanding Shares
246,624,000
Free Float
N/A
Market Cap
C$67.82 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. George Scorsis (Age 45)
    Interim CEO & Exec. Chair of the Board
    Comp: $200.68k
  • Mr. Angelo Tsebelis
    Advisor
  • Mr. Jason Alexander
    Chief Strategy Officer & Director
  • Ms. Beth Carreon
    Chief Financial Officer
  • Mr. Jeff Keyes
    VP of Operations
  • Dr. Alexandre Sibilev
    Vice-Pres of Quality Assurance & Global Regulatory Compliance
  • Ms. Marianella delaBarrera
    VP of Communications & Corp. Affairs
  • Mr. Joseph Mele
    Sr. VP of Commercial, Sales & Marketing
  • Ms. Deborah Sikkema
    Chief People Officer
  • Mr. Michael P. Kraft (Age 58)
    Strategic Advisor to the board

Key Competitors

View All Competitors

WMD Stock Analysis - Frequently Asked Questions

How have WMD shares performed in 2024?

WeedMD's stock was trading at C$0.28 on January 1st, 2024. Since then, WMD shares have increased by 0.0% and is now trading at C$0.28.
View the best growth stocks for 2024 here.

What other stocks do shareholders of WeedMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other WeedMD investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Cara Therapeutics (CARA), Cronos Group (CRON), Tencent (TCEHY), Aduro Biotech (ADRO), Auxly Cannabis Group (CBWTF).

How do I buy shares of WeedMD?

Shares of WMD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:WMD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Fed launches fourth dollar overhaul
Stansberry Research